With the debut of remarkably effective weight-loss drugs, America's high obesity rate and its uniquely astronomical prescription drug pricing appear to be set on a catastrophic collision course.
If just half of the adults in the US with obesity start taking a new weight-loss drug, such as Wegovy, the collective cost would reach an estimated $411 billion per year.
[
add
]
[
|
|
...
]